Clinical Trials
5
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
154
CANADA:77
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN
Phase 3
Recruiting
- Conditions
- Chemotherapy-induced Polyneuropathy
- Interventions
- Drug: PlaceboDrug: Aconite pain oil
- First Posted Date
- 2024-01-02
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- WALA Heilmittel GmbH
- Target Recruit Count
- 350
- Registration Number
- NCT06186479
- Locations
- 🇩🇪
Medizinische Fakultät Mannheim der Uniklinik Heidelberg, Mannheim, Germany
News
No news found